Announcements Trials
Browse Landscape

Phase

Phase 2 154Phase 1 49Phase 3 41Phase 1/2 29Phase 2/3 5Phase NA 3Phase 4 3Phase EARLY_PHASE1 1

Status

Completed 17Unknown 11Recruiting 8Terminated 3Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1

Conditions

Stomach Neoplasms 1Pancreatic Neoplasms 1Esophageal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Radiosurgery 28Magnetic Resonance Spectroscopy 25Blood Specimen Collection 20Radiotherapy 19Surveys and Questionnaires 18Exercise 16Early Intervention, Educational 16Methods 15Cyclophosphamide 15Surgical Procedures, Operative 14Standard of Care 14Radiotherapy, Intensity-Modulated 14Biopsy 13Acupuncture Therapy 12Interviews as Topic 11Cisplatin 11Filgrastim 10Educational Status 10Radiofrequency Ablation 9Magnetic Resonance Imaging 9Fluorodeoxyglucose F18 9fludarabine phosphate 8Radiation 8Gemcitabine 8X-Rays 7Sorafenib 7Practice Guidelines as Topic 7Granulocyte Colony-Stimulating Factor 7Colonoscopy 7Capecitabine 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Terminated × Docetaxel × Clear all
NCT02145078 2020-09-24

Gene Expression Levels in Predicting Treatment Response in Patients With Stage IV Non-small Cell Lung Cancer

Barbara Ann Karmanos Cancer Institute

Phase NA Terminated
4 enrolled 7 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02358863 2018-09-06

mEGA

Georgetown University

Phase NA Terminated
13 enrolled 6 charts
Gastrointestinal

Esophageal Neoplasms, Stomach Neoplasms

NCT00159471 2014-05-22

Genes as Predictors of Response to Gemcitabine, Docetaxel, and Capecitabine (GTX) in Metastatic or Unresectable Pancreatic Cancer.

University of Southern California

Phase NA Terminated
1 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡